182 related articles for article (PubMed ID: 25735935)
1. Signal transduction in inherited metabolic disorders: a model for a possible pathogenetic mechanism.
Boneh A
J Inherit Metab Dis; 2015 Jul; 38(4):729-40. PubMed ID: 25735935
[TBL] [Abstract][Full Text] [Related]
2. Inflammasome, mTORC1 activation, and metabolic derangement contribute to the susceptibility of diabetics to infections.
Krakauer T
Med Hypotheses; 2015 Dec; 85(6):997-1001. PubMed ID: 26384528
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
[TBL] [Abstract][Full Text] [Related]
4. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.
Viollet B; Mounier R; Leclerc J; Yazigi A; Foretz M; Andreelli F
Diabetes Metab; 2007 Dec; 33(6):395-402. PubMed ID: 17997341
[TBL] [Abstract][Full Text] [Related]
5. AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer.
Hardie DG
Biochem Soc Trans; 2011 Jan; 39(1):1-13. PubMed ID: 21265739
[TBL] [Abstract][Full Text] [Related]
6. Fatty acids and cell signal transduction.
Graber R; Sumida C; Nunez EA
J Lipid Mediat Cell Signal; 1994 Mar; 9(2):91-116. PubMed ID: 8012764
[TBL] [Abstract][Full Text] [Related]
7. Role of fatty acids in signal transduction: modulators and messengers.
Sumida C; Graber R; Nunez E
Prostaglandins Leukot Essent Fatty Acids; 1993 Jan; 48(1):117-22. PubMed ID: 7678706
[TBL] [Abstract][Full Text] [Related]
8. Rho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in mice.
Noda K; Nakajima S; Godo S; Saito H; Ikeda S; Shimizu T; Enkhjargal B; Fukumoto Y; Tsukita S; Yamada T; Katagiri H; Shimokawa H
PLoS One; 2014; 9(11):e110446. PubMed ID: 25365359
[TBL] [Abstract][Full Text] [Related]
9. Extracellular cAMP activates molecular signalling pathways associated with sperm capacitation in bovines.
Alonso CAI; Osycka-Salut CE; Castellano L; Cesari A; Di Siervi N; Mutto A; Johannisson A; Morrell JM; Davio C; Perez-Martinez S
Mol Hum Reprod; 2017 Aug; 23(8):521-534. PubMed ID: 28521061
[TBL] [Abstract][Full Text] [Related]
10. The signalling profile of recombinant human orexin-2 receptor.
Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
[TBL] [Abstract][Full Text] [Related]
11. A combined docosahexaenoic acid-thyroid hormone protocol upregulates rat liver β-Klotho expression and downstream components of FGF21 signaling as a potential novel approach to metabolic stress conditions.
Vargas R; Riquelme B; Fernández J; Videla LA
Food Funct; 2017 Nov; 8(11):3980-3988. PubMed ID: 28990606
[TBL] [Abstract][Full Text] [Related]
12. Human Protein Kinases and Obesity.
Engin A
Adv Exp Med Biol; 2017; 960():111-134. PubMed ID: 28585197
[TBL] [Abstract][Full Text] [Related]
13. Targeting bile-acid signalling for metabolic diseases.
Thomas C; Pellicciari R; Pruzanski M; Auwerx J; Schoonjans K
Nat Rev Drug Discov; 2008 Aug; 7(8):678-93. PubMed ID: 18670431
[TBL] [Abstract][Full Text] [Related]
14. HC toxin (a HDAC inhibitor) enhances IRS1-Akt signalling and metabolism in mouse myotubes.
Tan HW; Sim AY; Huang SL; Leng Y; Long YC
J Mol Endocrinol; 2015 Dec; 55(3):197-207. PubMed ID: 26373795
[TBL] [Abstract][Full Text] [Related]
15. The Anticancer Agent, Di-2-Pyridylketone 4,4-Dimethyl-3-Thiosemicarbazone (Dp44mT), Up-Regulates the AMPK-Dependent Energy Homeostasis Pathway in Cancer Cells.
Krishan S; Richardson DR; Sahni S
Biochim Biophys Acta; 2016 Dec; 1863(12):2916-2933. PubMed ID: 27639899
[TBL] [Abstract][Full Text] [Related]
16. AMPK activators--potential therapeutics for metabolic and other diseases.
Zhou G; Sebhat IK; Zhang BB
Acta Physiol (Oxf); 2009 May; 196(1):175-90. PubMed ID: 19245659
[TBL] [Abstract][Full Text] [Related]
17. eNOS activation mediated by AMPK after stimulation of endothelial cells with histamine or thrombin is dependent on LKB1.
Thors B; Halldórsson H; Thorgeirsson G
Biochim Biophys Acta; 2011 Feb; 1813(2):322-31. PubMed ID: 21145922
[TBL] [Abstract][Full Text] [Related]
18. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases.
Incalza MA; D'Oria R; Natalicchio A; Perrini S; Laviola L; Giorgino F
Vascul Pharmacol; 2018 Jan; 100():1-19. PubMed ID: 28579545
[TBL] [Abstract][Full Text] [Related]
20. Ox-Lp(a) transiently induces HUVEC autophagy via an ROS-dependent PAPR-1-LKB1-AMPK-mTOR pathway.
Li GH; Lin XL; Zhang H; Li S; He XL; Zhang K; Peng J; Tang YL; Zeng JF; Zhao Y; Ma XF; Lei JJ; Wang R; Wei DH; Jiang ZS; Wang Z
Atherosclerosis; 2015 Nov; 243(1):223-35. PubMed ID: 26407666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
